News

Breaking news coverage from cryptocurrency world about key figures, exchanges, startups, investment, applications, regulation and more.

Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research
By August 18th, 2021
Press Release

Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research

By August 18th, 2021

Molecule, a decentralised biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. In a historic transaction, the first biopharma IPNFT was successfully transferred to research collective VitaDAO to fund novel longevity therapeutics at the University of Copenhagen.